Patron Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.19M Buy
5,646
+4
+0.1% +$4.05K 2.29% 8
2025
Q4
$6.06M Buy
5,642
+484
+9% +$463K 2.7% 7
2025
Q3
$3.94M Buy
5,158
+1,190
+30% +$886K 1.78% 11
2025
Q2
$3.09M Buy
3,968
+250
+7% +$194K 1.53% 11
2025
Q1
$3.07M Buy
3,718
+157
+4% +$131K 1.66% 10
2024
Q4
$2.75M Buy
3,561
+28
+0.8% +$23.2K 1.49% 12
2024
Q3
$3.13M Sell
3,533
-25
-0.7% -$22.5K 1.73% 9
2024
Q2
$3.22M Sell
3,558
-45
-1% -$36K 1.89% 9
2024
Q1
$2.8M Buy
3,603
+3
+0.1% +$2.13K 1.71% 11
2023
Q4
$2.1M Buy
3,600
+323
+10% +$189K 1.39% 11
2023
Q3
$1.76M Buy
3,277
+55
+2% +$28.3K 1.3% 14
2023
Q2
$1.51M Sell
3,222
-24
-0.7% -$10.1K 1.07% 18
2023
Q1
$1.11M Sell
3,246
-2
-0.1% -$675 0.82% 29
2022
Q4
$1.19M Buy
3,248
+11
+0.3% +$3.9K 0.89% 24
2022
Q3
$1.05M Sell
3,237
-43
-1% -$13.6K 0.87% 26
2022
Q2
$1.06M Buy
3,280
+361
+12% +$108K 0.84% 29
2022
Q1
$835K Sell
2,919
-30
-1% -$7.72K 0.57% 46
2021
Q4
$815K Hold
2,949
0.53% 45
2021
Q3
$681K Buy
2,949
+8
+0.3% +$1.97K 0.5% 51
2021
Q2
$675K Sell
2,941
-218
-7% -$43.8K 0.51% 50
2021
Q1
$590K Buy
3,159
+229
+8% +$44.8K 0.5% 56
2020
Q4
$495K Buy
+2,930
New +$437K 0.48% 57

Other funds holding LLY

Patron Partners's LLY Position: Q1 2026 in Review

Patron Partners increased its Eli Lilly (LLY) stake by 0.07% in Q1 2026, buying an estimated $4.05K and bringing the position to 5,646 shares worth $5.19M. The position accounts for 2.29% of the portfolio, ranked #8.

Patron Partners first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $6.06M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Patron Partners held 5,646 shares of Eli Lilly worth $5.19M as of Q1 2026.
  • Patron Partners bought 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
  • Eli Lilly made up 2.29% of Patron Partners's portfolio in Q1 2026, its #8 holding.
  • Patron Partners first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Patron Partners's Eli Lilly position peaked at $6.06M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Patron Partners's 13F filing for Q1 2026, filed 29 Apr 2026.